Authors:
WARNKE JP
WILDFEUER A
EIBEL G
PFAFF G
KLAMMER A
Citation: Jp. Warnke et al., PHARMACOKINETICS OF AMPICILLIN SULBACTAM IN PATIENTS UNDERGOING SPINAL MICRONEUROSURGICAL PROCEDURES/, International journal of clinical pharmacology and therapeutics, 36(5), 1998, pp. 253-257
Authors:
NICHTERLEIN T
KRETSCHMAR M
SCHADT A
MEYER A
WILDFEUER A
LAUFEN H
HOF H
Citation: T. Nichterlein et al., REDUCED INTRACELLULAR ACTIVITY OF ANTIBIOTICS AGAINST LISTERIA-MONOCYTOGENES IN MULTIDRUG-RESISTANT CELLS, International journal of antimicrobial agents, 10(2), 1998, pp. 119-125
Authors:
WILDFEUER A
NEU IS
SAFAYHI H
METZGER G
WEHRMANN M
VOGEL U
AMMON HPT
Citation: A. Wildfeuer et al., EFFECTS OF BOSWELLIC ACIDS EXTRACTED FROM A HERBAL MEDICINE ON THE BIOSYNTHESIS OF LEUKOTRIENES AND THE COURSE OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Arzneimittel-Forschung, 48(6), 1998, pp. 668-674
Authors:
SCHMALRECK AF
KOTTMANN I
REISER A
RUFFER U
SCHLENK R
VANCA E
WILDFEUER A
Citation: Af. Schmalreck et al., SUSCEPTIBILITY TESTING OF MACROLIDE AND LINCOSAMIDE ANTIBIOTICS ACCORDING TO DIN GUIDELINES, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 179-187
Authors:
WILDFEUER A
MALLWITZ J
GOTTHARDT H
HILLE E
GRUBER H
DAHMEN G
PFAFF G
GOBEL C
Citation: A. Wildfeuer et al., PHARMACOKINETICS OF AMPICILLIN, SULBACTAM AND CEFOTIAM IN PATIENTS UNDERGOING ORTHOPEDIC-SURGERY, Infection, 25(4), 1997, pp. 258-262
Citation: A. Wildfeuer et A. Haberreiter, INTRACELLULAR ACTIVITY OF AZITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM COMPLEX IN HUMAN MACROPHAGES, Arzneimittel-Forschung, 47(7), 1997, pp. 866-868
Authors:
WILDFEUER A
SEIDL HP
PAULE I
HABERREITER A
Citation: A. Wildfeuer et al., IN-VITRO ACTIVITY OF VORICONAZOLE AGAINST YEASTS, MOLDS AND DERMATOPHYTES IN COMPARISON WITH FLUCONAZOLE, AMPHOTERICIN-B AND GRISEOFULVIN, Arzneimittel-Forschung, 47(11), 1997, pp. 1257-1263
Citation: A. Wildfeuer et al., DETECTION OF CANDIDA-ALBICANS DNA WITH A YEAST-SPECIFIC PRIMER SYSTEMBY POLYMERASE CHAIN-REACTION, Mycoses, 39(9-10), 1996, pp. 341-346
Authors:
WILDFEUER A
LAUFEN H
YEATES RA
ZIMMERMANN T
Citation: A. Wildfeuer et al., A NEW PHARMACEUTICAL CONCEPT FOR THE TREATMENT OF OROPHARYNGEAL AND ESOPHAGEAL CANDIDOSIS WITH FLUCONAZOLE, Mycoses, 39(9-10), 1996, pp. 357-360
Authors:
WILDFEUER A
LAUFEN H
SCHMALRECK AF
YEATES RA
ZIMMERMANN T
Citation: A. Wildfeuer et al., FLUCONAZOL - COMPARISON OF PHARMACOKINETI CS, THERAPY AND IN-VITRO SUSCEPTIBILITY OF YEASTS, Mycoses, 39, 1996, pp. 51-57
Authors:
WILDFEUER A
LAUFEN H
YEATES RA
ZIMMERMANN T
Citation: A. Wildfeuer et al., A NEW PHARMACEUTICAL CONCEPT FOR THE TREA TMENT OF OROPHARYNGEAL AND ESOPHAGEAL CANDIDOSIS WITH FLUCONAZOLE, Mycoses, 39, 1996, pp. 123-126
Citation: A. Wildfeuer et K. Rader, STABILITY OF BETA-LACTAMASE INHIBITORS AND BETA-LACTAM ANTIBIOTICS INPARENTERAL DOSAGE FORMS AND IN BODY-FLUIDS AND TISSUE-HOMOGENATES - ACOMPARATIVE-STUDY OF SULBACTAM, CLAVULANIC ACID, AMPICILLIN AND AMOXICILLIN (REPRINTED FROM ARZNEIM FORSCH, VOL 41, PG 70, 1991), International journal of antimicrobial agents, 6, 1996, pp. 31-34
Citation: M. Wenzel et al., PHARMACOKINETICS OF AMPICILLIN-SULBACTAM IN PATIENTS UNDERGOING COLORECTAL SURGERY - MEASUREMENTS IN SERUM, THE COLONIC WALL AND IN TISSUE AT THE INCISION SITE, International journal of antimicrobial agents, 6, 1996, pp. 35-39
Citation: A. Wildfeuer et al., UPTAKE OF AZITHROMYCIN BY VARIOUS CELLS AND ITS INTRACELLULAR ACTIVITY UNDER IN-VIVO CONDITIONS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 75-79
Authors:
ZIMMERMANN T
YEATES RA
LAUFEN H
SCHARPF F
LEITOLD M
WILDFEUER A
Citation: T. Zimmermann et al., INFLUENCE OF THE ANTIBIOTICS ERYTHROMYCIN AND AZITHROMYCIN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIDAZOLAM, Arzneimittel-Forschung, 46(2), 1996, pp. 213-217
Authors:
YEATES RA
ZIMMERMANN T
LAUFEN H
ALBRECHT M
WILDFEUER A
Citation: Ra. Yeates et al., COMPARATIVE PHARMACOKINETICS OF FLUCONAZOLE AND OF ITRACONAZOLE IN JAPANESE AND IN GERMAN SUBJECTS, International journal of clinical pharmacology and therapeutics, 33(3), 1995, pp. 131-135
Authors:
AUST R
KRUSE FE
WILDFEUER A
PFAFF G
ROHRSCHNEIDER K
VOLCKER HE
Citation: R. Aust et al., BIOLOGICALLY-ACTIVE CONCENTRATIONS OF FLUCONAZOLE IN HUMAN AQUEOUS-HUMOR AND VITREOUS AFTER ORAL APPLICATION, Investigative ophthalmology & visual science, 36(4), 1995, pp. 154-154
Citation: A. Wildfeuer et Hp. Seidl, COMPARISON OF THE IN-VITRO ACTIVITY OF FLUCONAZOLE AGAINST CANDIDA-ALBICANS AND DERMATOPHYTES, Arzneimittel-Forschung, 45(7), 1995, pp. 819-821
Authors:
ZIMMERMANN T
SCHLENK R
PFAFF G
LACH P
WILDFEUER A
Citation: T. Zimmermann et al., PREDICTION OF PHENOTYPE FOR DEXTROMETHORPHAN O-DEMETHYLATION BY USINGPOLYMERASE CHAIN-REACTION IN HEALTHY-VOLUNTEERS, Arzneimittel-Forschung, 45-1(1), 1995, pp. 41-43
Citation: A. Wildfeuer et al., DISTRIBUTION OF ORALLY-ADMINISTERED AZITHROMYCIN IN VARIOUS BLOOD COMPARTMENTS, International journal of clinical pharmacology and therapeutics, 32(7), 1994, pp. 356-360
Citation: P. Schramm et al., DETERMINATION OF FLUCONAZOLE CONCENTRATIONS IN THE PROSTATIC AND SEMINAL-VESICLE FLUID (SPLIT EJACULATE), Mycoses, 37(11-12), 1994, pp. 417-420
Citation: A. Wildfeuer et Hp. Seidl, THE IN-VITRO ACTIVITY OF FLUCONAZOLE AGAINST FUNGI INVOLVED IN DERMALINFECTIONS, Mycoses, 37(11-12), 1994, pp. 447-449